Epithelial barriers in allergy and asthma.

Area of Science:

• Immunology
• Respiratory Medicine
• Cell Biology

Background:

• The respiratory epithelium acts as a critical barrier against environmental insults.
• Compromised epithelial barriers trigger immune responses, leading to chronic inflammatory diseases like allergic rhinitis, chronic rhinosinusitis, and asthma.
• Dysfunctional airway epithelium, characterized by disrupted tight junctions, is implicated in these conditions.

Purpose of the Study:

• To review and discuss epithelial barrier defects in type 2-driven chronic airway inflammation.
• To explore the role of newly identified epithelial cell types in respiratory disease chronicity.
• To examine current clinical challenges in diagnosing and treating related conditions.

Main Methods:

• Review of current literature on respiratory epithelial barrier function.
• Analysis of single-cell transcriptomics data to identify novel epithelial cell types.
• Discussion of diagnostic and therapeutic strategies targeting epithelial barrier defects.

Main Results:

• Epithelial barrier defects are key in the pathophysiology of allergic rhinitis, chronic rhinosinusitis, and asthma.
• Single-cell transcriptomics reveals novel epithelial cell populations contributing to disease chronicity.
• Current diagnostic and treatment approaches face clinical challenges.

Conclusions:

• Epithelial barrier dysfunction is a unifying factor in upper and lower airway type 2 inflammation.
• Understanding novel epithelial cell roles is crucial for targeted therapies.
• Addressing clinical challenges is essential for improved patient outcomes in allergic rhinitis, chronic rhinosinusitis, and asthma.